| Literature DB >> 29744438 |
Ming Li1,2,3, Pan Xiong2, Feng Yan4, Sijie Li3, Changhong Ren3, Zhichen Yin1,3, Ang Li5, Huafang Li2,6, Xunming Ji1,3,4, Yufeng Zheng2, Yan Cheng2.
Abstract
Hydroxyapatite (HA) is an attractive bioceramic for hard tissue repair and regeneration due to its physicochemical similarities to natural apatite. However, its low fracture toughness, poor tensile strength and weak wear resistance become major obstacles for potential clinical applications. One promising method to tackle with these problems is exploiting graphene and its derivatives (graphene oxide and reduced graphene oxide) as nanoscale reinforcement fillers to fabricate graphene-based hydroxyapatite composites in the form of powders, coatings and scaffolds. The last few years witnessed increasing numbers of studies on the preparation, mechanical and biological evaluations of these novel materials. Herein, various preparation techniques, mechanical behaviors and toughen mechanism, the in vitro/in vivo biocompatible analysis, antibacterial properties of the graphene-based HA composites are presented in this review.Entities:
Keywords: Biomedical devices; Bone tissue; Composites; Graphene; Hydroxyapatite
Year: 2018 PMID: 29744438 PMCID: PMC5935763 DOI: 10.1016/j.bioactmat.2018.01.001
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
Fig. 1The number of publications on Graphene-based HA composites from year 2009–2016 (2009 [16], 2011 [[17], [18], [19]], 2012 [[20], [21], [22], [23], [24]], 2013 [[25], [26], [27], [28], [29], [30], [31], [32]], 2014 [[33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49]], 2015 [[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82]], 2016 [[83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112]]). This figure does not include the papers published in 2017 [[113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130]].
Fig. 2The summary of different preparation methods of the graphene-based composites.
Fig. 3(a) The proposed in situ synthesis mechanism of HA on pristine GO sheets. The SEM and TEM images of GO–HA (b–d) composites, the insets of insets (d) show the selected area electron diffraction (SAED) patterns of the corresponding composites. The black arrows of (b) point to the wrinkles of the GO sheets. These figures were adapted from Ref. [30].
Fig. 4SEM images of the surfaces of (a) HA, (b) 0.5 wt% graphene/HA composite and (c) 1.0 wt% graphene/HA composite [25].
Fig. 5(a) Schematic illustration of the EPD process (b) The TEM images of the HA nanoparticles with 2 wt% GO sheets (c) The SEM images of composite coatings containing (c) 0 wt%, (d) 2 wt% GO and (e) 5 wt% GO sheets, and corresponding optical photos. These figures were adapted from Ref. [38].
Fig. 6FESEM views of the as-deposited nanostructured coatings, (a) the pure HA coating, (b) the HA-0.1 wt% graphene coating, and (c) the HA-1.0 wt% graphene coating. −1: surface view, −2: magnified surface view, and −3: cross-sectional view. The white arrow head points to graphene located on the surfaces of the coatings, and magnified views of typical areas from the cross-section of the HA-graphene coating showing clearly the presence of GN in the coating and at the coating/substrate interface (c-3). Graphene -induced layered structure is clearly seen for the HA-graphene coatings.
Fig. 7Scanning electron micrographs of the composite scaffolds. The inset demonstrates the photograph of the scaffolds. Note: GHA: gelatin-HA scaffold, GOGHA 0.5: gelatin-HA scaffold with 0.5 wt% GO, GOGHA1.0: gelatin-HA scaffold with1 wt% GO [68].
Fig. 8SEM images of PLA/HA/GO nanofibers with high magnification (a) and low magnification (c), electrospun PLA with high magnification (b) and low magnification (d) [23].
Fig. 9Scheme illustration for GO modification of b-TCP bioceramics stimulates the in vivo osteogenesis [69].
Fig. 10(A) Schematic showing that the self-assembly of RGO and nHA to form a porous RGO scaffold for cranial bone defect reconstruction; (B) Tyndall effect of before and after reaction [122].
Fig. 11Characteristic toughening mechanisms at a striation line in the composites with 1.5 wt% rGO: Vicker's indentation craters (a) and radial cracks: crack branching (b), crack bridging (c and f), pull out (d and f), crack deflection (e) [44].
Fig. 12Restrained HA grain growth by graphene and abnormal growth of the grain along the direction parallel to graphene, (a) TEM image of the HA-graphene composites showing that graphene is predominantly located at the HA grain boundaries, forming a serial wall zones isolating individual HA grains, and abnormal HA grain growth is seen along the direction parallel to graphene, and (b) schematic depiction of the composites illustrating evolvement of the HA grains during the SPS processing and following heat treatment.
Fig. 13The ARS stain and its corresponding extract in MC3T3-E1 cells incubated with a colloidal dispersion of HAp particles, rGO nanosheets or rGO/HAp nanocomposites in basal media. (A) Increased calcium deposits by rGO/HAp nanocomposites were not related to the cell number (scale bars = 200 μ m). There was a notable formation of calcium deposits by rGO/HAp nanocomposites from 14 d. (B) The dissolved ARS extracted from the staining plates confirmed that the rGO/HAp nanocomposites significantly (p < .05) increased extracellular calcium deposition in the cells [63].
Fig. 14SEM images of the adhered platelets on pristine (a) Ti, (b) SF, (c) SF/GO, (d) SF/HA and (e) SF/GO/HA coatings [88].
Fig. 15Schematic illustration of the mineralization process for a GNS/HA composite immersed in SBF. (a) Dissolution controlled stage, in which calcium ions dissolution is predominant, leading to negatively charged surface. (b) Precipitation controlled stage, in which negatively charged surface together with more nucleation sites attract calcium ions from SBF to form the Ca-rich layer. (c) Formation of bone-like apatite, in which Ca-rich layer attracts phosphate ions and form bone-like apatite [25].
Fig. 16Histological observations. (A) Images from HE staining: non-treated control (a–c), the defects treated with the HAp grafts (d–f), the defect treated with rGO/HAp grafts (g–i) Original magnifications: × 12.5 in (a,d,g) and × 50 in the others. (B) Images from MT staining. (a,b) HAp grafts and (c,d) rGO/HAp grafts. Original magnifications: × 100. Symbols: nb, new bone; s, soft tissue; fv, fibrovascular tissue; *, graft materials. (C) New bone formation (%) [63].
Fig. 17Micro-CT analysis of in vivo bone formation ability for β-TCP and β-TCP-GRA scaffolds after being implanted in the cranial bone defects of rabbits for 4 and 8 weeks.*Significant difference between the b-TCP and b-TCP-GRA groups (p < .05). Note: β-TCP-GRA represents GO-modified β-tricalcium phosphate andβ-TCP represents β-tricalcium phosphate [69].
Fig. 18SEM images (a) of the S. aureus after incubation 12 h with the pristine Ti (1) and different coating interfaces: HA (2), chitosan/HA (3), GO/chitosan/HA (4). The black arrows in (3), (4) point to the adherent S. aureus. Scale bar 3 μm. Schematic illustration (b) of the speculated antibacterial adhesion mechanism of the GO/chitosan/HA nanocomposites.